Department of Clinical Neuroscience
At the Department of Clinical Neuroscience (CNS), we conduct research and teaching regarding the function of the brain - from a molecular level to the effect on society.
Glaucoma researcher Pete Williams is awarded the 2023 Pfizer Ophthalmics Carl Camras Translational Research Award
Pete Williams and his research team have focused on studying and understanding the changes in the eye that lead to glaucoma rather than managing the risk factors. Several studies on how nicotinamide (a variant of vitamin B) can slow down the degenerating processes and protect the optic nerve have led to the start of a larger clinical study in the spring of 2022.
Kristina Teär Fahnehjelm - New adjunct professor in ophthalmology
On January 24, 2023, Kristina Teär Fahnehjelm was employed as adjunct professor of ophthalmology at the Department of Clinical Neuroscience. The position is combined with Kristina's work as a doctor at St. Erik's Eye Hospital.
Doctoral funding from KI strengthens research on lack of oxygen in the eye tissue
Research group leader Helder André at St. Erik's Eye Hospital and Karolinska Institutet has been awarded funding from KI's special grants for doctoral education. The funding enables the employment of a doctoral student for the project The importance of oxygen deficiency for the emergence of vascular diseases in the eye for four years.
Glaucoma research receives 4,8 MSEK grant from the Swedish Research Council
Pete Williams, Associate Professor at Karolinska Institutet and St. Erik Eye Hospital, has been granted 4,8 MSEK from the Swedish Research Council.
Over the next four years, Pete Williams' research group will develop protective treatments for the nerve cells that are broken down in glaucoma and other eye diseases, focusing on the metabolism of the NAD, an important metabolite for the health of the neuron.
Research award to Johan Franck
CAN's Drug Research Prize 2022 is awarded to Professor and Chief Physician Johan Franck.
Notable article on Alzheimer's in The Conversation
In just 4 days, 130,000 people have read the article Alzheimer's disease: surprising new theory about what might cause it, written by Andrea Sturchio at CNS together with researchers at Labmed. This makes it KI's second most read article in The Conversation this year.
World-leading MS researcher recruited to Karolinska Institutet
The multiple sclerosis (MS) research consortium at Karolinska institutet is further strengthened by the recruitment of the distinguished MS scientist, Roland Martin.
Environment and Sustainable Development at CNS
We as part of a University has a central roll in the work to combat climate change, both by contributing through teaching and research, but we also need to contribute by reducing the impact of our own activities. Here you can find tips on what changes you can do in your daily life to reduce your climate footprint.
GDPR at KI
The General Data Protection Regulation (GDPR, or Dataskyddsförordningen) for the processing of personal data is to be applied on May 25 2018 in Sweden. Here you will find information on GDPR and the implementation of the regulation at KI.